Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical developme... Read more
Ani Pharmaceuticals
2 followers
Klarisana
1 follower
Bristol-Myers Squibb
319 followers
Walgreens Boots Alliance
144 followers
Astellas Pharma
63 followers
Viatris
54 followers
NYU Langone Health
51 followers
Alnylam Pharmaceuticals
50 followers
Syneos Health
38 followers
Catalent
35 followers
Omnicell
32 followers
Organon
29 followers